Back to top

Regeneron price target raised to $824 from $641 at Leerink

Leerink analyst David Risinger raised the firm’s price target on Regeneron (REGN) to $824 from $641 and keeps a Market Perform rating on the shares...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Regeneron Pharmaceuticals, Inc. (REGN)